---
schema_version: "secwatch.filing_event.v1"
accession: "0001048477-25-000086"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:43:34.241568+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BioMarin appoints Ian T. Clark to Board of Directors effective August 1, 2025

## Summary
- Board size increased from ten to eleven members to accommodate Clark's appointment.
- Clark appointed to Audit Committee and Science and Technology Committee.
- Received RSU grant valued at $400,000 under 2017 Equity Incentive Plan.
- Will receive standard non-employee director fees and committee retainers as outlined in proxy statement.

## SEC filing metadata
- accession: 0001048477-25-000086
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/0001048477-25-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/bmrn-20250730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001048477-25-000086
- JSON: https://secwatch.observer/filing/0001048477-25-000086.json
- Plain text: https://secwatch.observer/filing/0001048477-25-000086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.